These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 38303494)
1. Advances in the research and application of neurokinin-1 receptor antagonists. Hong X; Ma J; Zheng S; Zhao G; Fu C J Zhejiang Univ Sci B; 2024 Feb; 25(2):91-105. PubMed ID: 38303494 [TBL] [Abstract][Full Text] [Related]
2. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant. Coveñas R; Rodríguez FD; Robinson P; Muñoz M Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958914 [TBL] [Abstract][Full Text] [Related]
3. Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy? Robinson P; Coveñas R; Muñoz M Curr Med Chem; 2023; 30(16):1798-1812. PubMed ID: 35959620 [TBL] [Abstract][Full Text] [Related]
4. The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists. Muñoz M; González-Ortega A; Rosso M; Robles-Frias MJ; Carranza A; Salinas-Martín MV; Coveñas R Peptides; 2012 Dec; 38(2):318-25. PubMed ID: 23026680 [TBL] [Abstract][Full Text] [Related]
5. The use of SP/Neurokinin-1 as a Therapeutic Target in Colon and Rectal Cancer. Martín-García D; Téllez T; Redondo M; García-Aranda M Curr Med Chem; 2024; 31(39):6487-6509. PubMed ID: 37861026 [TBL] [Abstract][Full Text] [Related]
6. Triple Negative Breast Cancer: How Neurokinin-1 Receptor Antagonists Could Be Used as a New Therapeutic Approach. Muñoz M; Rosso M; Coveñas R Mini Rev Med Chem; 2020; 20(5):408-417. PubMed ID: 31721701 [TBL] [Abstract][Full Text] [Related]
7. Antagonism of NK-1R using aprepitant suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. Liu X; Zhu Y; Zheng W; Qian T; Wang H; Hou X Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1628-1634. PubMed ID: 31010320 [TBL] [Abstract][Full Text] [Related]
8. Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression. Mohammadi F; Javid H; Afshari AR; Mashkani B; Hashemy SI Mol Biol Rep; 2020 Jun; 47(6):4263-4272. PubMed ID: 32436041 [TBL] [Abstract][Full Text] [Related]
9. Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload. Ge C; Huang H; Huang F; Yang T; Zhang T; Wu H; Zhou H; Chen Q; Shi Y; Sun Y; Liu L; Wang X; Pearson RB; Cao Y; Kang J; Fu C Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19635-19645. PubMed ID: 31488714 [TBL] [Abstract][Full Text] [Related]
10. Aprepitant limits in vivo neuroinflammatory responses in a rhesus model of Lyme neuroborreliosis. Martinez AN; Burmeister AR; Ramesh G; Doyle-Meyers L; Marriott I; Philipp MT J Neuroinflammation; 2017 Feb; 14(1):37. PubMed ID: 28202084 [TBL] [Abstract][Full Text] [Related]
11. Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme. Afshari AR; Motamed-Sanaye A; Sabri H; Soltani A; Karkon-Shayan S; Radvar S; Javid H; Mollazadeh H; Sathyapalan T; Sahebkar A Curr Med Chem; 2021; 28(24):4877-4892. PubMed ID: 33441062 [TBL] [Abstract][Full Text] [Related]
12. A Novel Mechanism of Endoplasmic Reticulum Stress- and c-Myc-Degradation-Mediated Therapeutic Benefits of Antineurokinin-1 Receptor Drugs in Colorectal Cancer. Shi Y; Wang X; Meng Y; Ma J; Zhang Q; Shao G; Wang L; Cheng X; Hong X; Wang Y; Yan Z; Cao Y; Kang J; Fu C Adv Sci (Weinh); 2021 Nov; 8(21):e2101936. PubMed ID: 34605226 [TBL] [Abstract][Full Text] [Related]
13. The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia. Muñoz M; Coveñas R J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32492831 [TBL] [Abstract][Full Text] [Related]
15. Neurokinin receptor antagonism: a patent review (2014-present). Muñoz M; Coveñas R Expert Opin Ther Pat; 2020 Jul; 30(7):527-539. PubMed ID: 32401556 [TBL] [Abstract][Full Text] [Related]
16. Varicella Zoster Virus Induces Nuclear Translocation of the Neurokinin-1 Receptor, Promoting Lamellipodia Formation and Viral Spread in Spinal Astrocytes. Bubak AN; Como CN; Blackmon AM; Frietze S; Mescher T; Jones D; Cohrs RJ; Paucek P; Baird NL; Nagel MA J Infect Dis; 2018 Sep; 218(8):1324-1335. PubMed ID: 29788447 [TBL] [Abstract][Full Text] [Related]
17. Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment. Mehboob R Biomed Pharmacother; 2021 Nov; 143():112159. PubMed ID: 34536760 [TBL] [Abstract][Full Text] [Related]
18. The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs. Munoz M; Covenas R; Esteban F; Redondo M J Biosci; 2015 Jun; 40(2):441-63. PubMed ID: 25963269 [TBL] [Abstract][Full Text] [Related]
19. Neurokinin-1 receptor antagonism improves postoperative neurocognitive disorder in mice. Li Z; Luo T; Ning X; Xiong C; Wu A Neurosci Lett; 2018 Nov; 687():189-195. PubMed ID: 30273701 [TBL] [Abstract][Full Text] [Related]
20. Association of Neurokinin-1 Receptor Signaling Pathways with Cancer. Rodriguez FD; Covenas R Curr Med Chem; 2024; 31(39):6460-6486. PubMed ID: 37594106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]